#
Jelmyto
  • Treatments
  • Urothelial Carcinoma
  • Jelmyto (Injection)

Jelmyto (Injection)

Generic name:mitomycin (injection route) [ mye-toe-MYE-sin ]
Drug class:Antibiotics / antineoplastics

Medically reviewed by Drugs.com. Last updated on Apr 14, 2022.

Commonly used brand name(s)

In the U.S.

  • Jelmyto

In Canada

  • mitoMYcin
  • Mutamycin

Available Dosage Forms:

  • Gel/Jelly

Therapeutic Class: Antibiotic

Uses for Jelmyto

Mitomycin injection is used to treat low-grade upper tract urothelial cancer (LG-UTUC). LG-UTUC is a type of cancer of the lining of the upper urinary tract (eg, lining of the kidney).

Mitomycin interferes with the growth of cancer cells, which are then destroyed by the body.

This medicine is to be given only by or under the direct supervision of your doctor.

Before using Jelmyto

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of mitomycin injection in the pediatric population. Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of mitomycin injection in the elderly.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with medicines

Although certain medicines should n...